Lobbying client
CORIUM
Commercial-stage biopharmaceutical company.
Filings
4
Filed by
1
Reported in-house
—
Reported by firms
$120,000
Filings
4 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Termination 3rd Quarter 2024
|
THORN RUN PARTNERS | $40,000 reported |
|
2nd Quarter - Report 2nd Quarter 2024
|
THORN RUN PARTNERS | $40,000 reported |
|
1st Quarter - Report 1st Quarter 2024
|
THORN RUN PARTNERS | $40,000 reported |
|
Registration 1st Quarter 2024
|
THORN RUN PARTNERS | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| THORN RUN PARTNERS | 3 | $120,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 4 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.